...
 Why us?  Why us? please click dropdown
4.8/5 out of 3,500+ reviews
Regulated: CQC Registered | 1-5796078466
  • Verified Content: Approved by the Women’s Health Clinic Clinical Team.
  • Educational Use: This is not a substitute for professional medical advice, diagnosis, or treatment.
  • Clinical Assessment: Individual suitability is determined by a clinician; results may vary.
  • MEDICAL EMERGENCY:

    If you need urgent help, use NHS 111. For a life-threatening emergency, call 999.

 Author  Find more about the author
Dr Farzana Khan

Dr Farzana Khan

Verified

Dr Farzana Khan qualified as an MD from the University of Copenhagen in 2003. She has worked in dermatology and obstetrics & gynaecology across the North of England and completed her MRCGP (CCT, 2013) and the Diploma of the Faculty of Sexual & Reproductive Health (2013). Her clinical focus is vaginal health—including dryness/GSM, sexual function concerns, lichen sclerosus, and comfort or volume changes. She offers careful assessment, discusses medical and conservative options first, and considers selected regenerative or aesthetic treatments where appropriate. Dr Farzana also trains clinicians as a KOL/Trainer with Neauvia, Asclepion Laser, and RegenLab (since 2023). Ongoing CPD includes IMCAS, CCR, ACE and expert training in women’s intimate fillers, PRP, and polynucleotide injectables. Her approach is simple: clear explanations, realistic expectations, and shared decision-making. Authored and medically reviewed by Dr Farzana Khan.

MD MRCGP DFFP
Was this answer helpful?
Rate Dr Farzana's explanation
faq Vaginal Laxity (postnatalmenopause support)

Does menopause-related GSM worsen the feeling of laxity?

Yes—genitourinary syndrome of menopause (GSM) can make you feel less supported because thinner, drier tissue increases friction, sting and micro-tears. That “looser yet sore” paradox often comes from surface changes and pelvic floor coordination rather than true structural widening. Treating GSM (moisturiser, lubricant, and if acceptable, low-dose local oestrogen) plus pelvic floor rehab usually restores comfort, confidence and predictability. Educational only. Results vary. Not a cure.

Clinical Context

Who is most affected? Peri- and post-menopausal women with dryness, burning, itching or dyspareunia who describe feeling less supported at the entrance. Breastfeeding women can experience a similar low-oestrogen state temporarily.

Who might need extra assessment first? Anyone with a visible/feelable bulge, tampon/cup slippage, air-trapping with gaping, the need to splint for bowels, or new post-menopausal bleeding. These suggest structural or safety issues that require medical review before any procedures.

Next steps now. Begin/continue a supervised pelvic floor block; schedule a vaginal moisturiser 2–4 nights weekly; use a generous, compatible lubricant; and discuss low-dose local oestrogen if acceptable. Reassess at 6–12 weeks using your diary of practical markers to judge progress.

Evidence-Based Approaches

NHS: plain-English overviews of vaginal dryness and GSM explain why lubrication and local oestrogen improve comfort and perceived support. NHS – vaginal dryness after menopause.

NICE menopause guideline (NG23) recommends vaginal moisturisers/lubricants and considering low-dose local vaginal oestrogen when symptoms affect quality of life; shared decision-making is emphasised. NICE – menopause.

BNF provides prescribing details and cautions for vaginal oestrogens used to treat atrophy/GSM, supporting safe, sustained symptom relief. BNF – vaginal oestrogens.

Cochrane reviews highlight benefits of pelvic floor muscle training for pelvic floor symptoms and vaginal oestrogen for post-menopausal vaginal symptoms, underscoring conservative-first care. Cochrane Library – pelvic floor & GSM.

PubMed (public abstracts) summarise GSM pathophysiology (epithelial thinning, pH change, microbiome shifts) and reductions in dyspareunia with local oestrogen, explaining why GSM can be misread as ‘laxity’. GSM overview – PubMed.